GET THE APP

..

Clinical Depression

ISSN: 2572-0791

Open Access

Citations Report

Clinical Depression : Citations & Metrics Report

Articles published in Clinical Depression have been cited by esteemed scholars and scientists all around the world.

Clinical Depression has got h-index 6, which means every article in Clinical Depression has got 6 average citations.

Following are the list of articles that have cited the articles published in Clinical Depression.

  2022 2021 2020 2019 2018

Year wise published articles

30 11 12 4 11

Year wise citations received

20 13 17 9 5
Journal total citations count 89
Journal impact factor 0.86
Journal 5 years impact factor 1.05
Journal cite score 1.18
Journal h-index 6
Journal h-index since 2018 4
Important citations

Bucur AM, Zampieri M, Dinu LP. An Exploratory Analysis of the Relation Between Offensive Language and Mental Health. arXiv preprint arXiv:2105.14888. 2021 May 31.

Mariño Z, Rodríguez?Tajes S, Bartrés C, Nácar L, Lens S, Navinés R, Cavero M, Londoño MC, Sastre L, Pocurull A, Dafieno A. Improvement of sexuality after hepatitis C cure with direct acting antivirals. Liver International. 2020 Dec;40(12):2972-7.

Nilakantam SR, Manohar S, Rao SS, Dayananda M, Mathur S, Gowdappa HB, Mahadevappa G, Raman R, Rao TS. Setting Up Psychosexual Medicine Unit: Insights From a Private University-Based Medical College Hospital. Journal of Psychosexual Health. 2020 Apr;2(2):179-85.

Sykes MM. Exploring the introduction of mandatory accreditation: the lived experiences of Australian early childhood workers (Doctoral dissertation, James Cook University).

Groot LD. The relationship between body dissatisfaction and sexual dysfunction: The mediating role of depression (Master's thesis).

Park JJ, Yoo KJ, Lee M, Park J, Park E, Tark JY, Lee S, Shin C. Research & Reviews: Journal of Medical and Health Sciences.

Krivosova M, Kertys M, Grendar M, Ondrejka I, Hrtanek I, Tonhajzerova I, Sekaninova N, Mokry J. Therapeutic Drug Monitoring of Venlafaxine and Impact of Age, Gender, BMI, and Diagnosis. Acta Facultatis Pharmaceuticae. 2020;67(1):33-7.

Salyakina D, Roy S, Wang W, Oliva M, Akhouri R, Sotto I, Mulas N, Solano R, Fernández JR, Sanchez S, Shamshad U. Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population. Molecular genetics & genomic medicine. 2019 Sep;7(9):e922.

Radouani F, Zass L, Hamdi Y, Rocha JD, Sallam R, Abdelhak S, Ahmed S, Azzouzi M, Benamri I, Benkahla A, Bouhaouala-Zahar B. A review of clinical pharmacogenetics Studies in African populations. Personalized medicine. 2020 Mar;17(2):155-70.

Tamblyn R, Bates DW, Buckeridge DL, Dixon WG, Girard N, Haas JS, Habib B, Iqbal U, Li J, Sheppard T. Multinational investigation of fracture risk with antidepressant use by class, drug, and indication. Journal of the American Geriatrics Society. 2020 Jul;68(7):1494-503.

Suwa?a J, Machowska M, Wiela-Hoje?ska A. Venlafaxine pharmacogenetics: a comprehensive review. Pharmacogenomics. 2019 Jun;20(11):829-45.

Han C, Wang SM, Bahk WM, Lee SJ, Patkar AA, Masand PS, Mandelli L, Pae CU, Serretti A. A pharmacogenomic-based antidepressant treatment for patients with major depressive disorder: results from an 8-week, randomized, single-blinded clinical trial. Clinical Psychopharmacology and Neuroscience. 2018 Nov;16(4):469.

Relevant Topics

arrow_upward arrow_upward